PETALING JAYA: The current supply of pharmaceuticals remains stable, whereby, on ave­rage, companies hold approximately three months of active pharmaceutical ingredients (APIs) and excipients and about two months of finished products. The Malaysian Organisation of Pharmaceutical Industries (Mopi) said this provides a buffer that supports continued supply of locally-manufactured essential medicines in the near term. However, there are early signs of price increases of APIs and plastic packaging materials as well as diesel and logistics costs. Malaysian Association of Phar­ma­ceutical Suppliers (MAPS) president Lim Teng Chyuan assu­red that supply remains diverse in terms of therapeutic category and sources, as members are mostly focused on generic sour­ces which are wholly imported. He pointed out that hydrocarbons are also required for powering machines used in the manufacturing process and are used as materials in the production of APIs, including solvents.

Source: The Star April 08, 2026 06:49 UTC